Lakefront Biotherapeutics (GLPGF) Share-based Compensation Growth (3y) (2019 - 2020)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Share-based Compensation Growth (3y) (2019 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 109.14% |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 5.27% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 12.91% |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 6.35% |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 17.49% |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 4.55% |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 2.68% |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -83.65% |
| Mar 31, 2020 | 46.79% |
| Jun 30, 2019 | 65.94% |
| Mar 31, 2019 | 48.14% |